Video Review: Talking Biopolitics
By Rebecca Dimond,
BioNews
| 10. 12. 2015
[cites CGS and CGS fellow Lisa Ikemoto]
Untitled Document
Watch Talking Biopolitics with George Annas and Lisa Ikemoto on YouTube
Genomic medicine has advanced rapidly in recent years and, with our increasing capacity to collect and store genetic information, it holds not only great promise but also pitfalls, for individuals and communities. This was the topic under discussion in a live video conversation on 7 October, organised by the Center for Genetics and Society.
The conversation was between Professor Lisa Ikemoto of the University of California, who was interviewing Professor George Annas, Director of the Center of Health Law, Ethics and Human Rights at Boston University, about his book Genomic Messages: How the Evolving Science of Genetics Affects our Health, Families, and Future'.
Professor Annas and his co-writer Sherman Elias (an obstetrician-gynaecologist, who died last year) have written a book that addresses important issues. The blurb on the back refers to 'an uncertain time' and one that is 'fraught with understandable and uncomfortable questions'. So I was intrigued to discover what topics the conversation would cover, and what 'uncomfortable questions' it might address.
Professor Annas...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...